Brain Scans Reveal How a Woman Voluntarily Enters a Psychedelic-Like Trance without Drugs

Why It Matters

The findings demonstrate a drug‑free pathway to study psychedelic‑like consciousness, offering a new model for neuroscience and mental‑health research. They suggest that intentional altered states can be reliably mapped, expanding therapeutic and cognitive‑science horizons.

Key Takeaways

• Voluntary trance shows decreased visual network connectivity.
• Frontoparietal control network connectivity increases during trance.
• fMRI reveals reproducible brain signatures across 20 sessions.
• Control group showed no similar network reorganization.
• Study provides drug‑free model for psychedelic research.

Pulse Analysis

Non‑ordinary states of consciousness—whether induced by meditation, sensory deprivation, or psychedelics—have long intrigued scientists, but isolating the brain mechanisms has been hampered by pharmacological confounds. By focusing on a self‑taught practitioner capable of entering a transcendental visionary state on command, researchers sidestepped drug effects and captured a pure neural signature of altered awareness. This approach aligns with a growing interest in drug‑free paradigms that can safely explore the architecture of consciousness while preserving participant autonomy.

Using functional magnetic resonance imaging, the team recorded 20 sessions in which the participant progressed from a baseline mental mode through a transitional phase to a fully developed trance. During the transition, brain connectivity became highly variable, reflecting a temporary destabilization of typical network organization. Once the trance was achieved, visual and somatomotor networks disengaged, reducing external sensory input, while frontoparietal and salience networks strengthened their coupling with the precuneus and temporal cortex. The resulting pattern exhibited lower entropy and higher statistical complexity, mirroring the structured, vivid imagery reported by the participant and resembling patterns observed in psychedelic studies.

The implications extend beyond academic curiosity. A reproducible, drug‑free model of psychedelic‑like experience offers a safer platform for investigating therapeutic mechanisms, such as ego attenuation and heightened internal focus, that underlie emerging psychedelic‑assisted therapies. However, the study’s single‑subject design and the participant’s unique synesthetic profile caution against overgeneralization. Future research must recruit diverse cohorts to delineate which neural reorganizations are universal to non‑ordinary states and which are idiosyncratic, paving the way for robust, translational applications in mental health and cognitive enhancement.